Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral nefopam after total knee arthroplasty
2020-002955-40Phase 2Active
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in postoperative pain comparing Oral nefopam with Placebo (2 arms). Primary endpoint: Total morphine consumption in the first 24 hours after surgery. Started May 2024; status: active.
02
Drugs
nefopam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2020-002955-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002955-40.